JLJennifer E. Lutomski

Jennifer E. Lutomski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jennifer E. Lutomski has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Determinants of Continuous Smartwatch Use and Data-Sharing Preferences With Physicians, Public Health Authorities, and Private Companies: Cross-Sectional Survey of Smartwatch Users

    by Anthony James Goodings, Kayode Philip Fadahunsi, Derjung M Tarn, Jennifer Lutomski, Allison Chhor, Frances Shiely, Patrick Henn, John O'DOnoghue

    Background: Smartwatches are widely adopted globally for tracking health metrics, offering potential for enhancing individual health care and public health efforts. Continuous use of the devices and users’ willingness to share the data collected are critical to realizing their full benefits. Objective: This study aimed to identify key factors that determine continuous smartwatch use and users’ comfort levels in sharing health data with health care providers and public health authorities. Methods: A cross-sectional online survey of current and past smartwatch users (aged >18 years) was conducted to assess determinants of continuous use based on the Expectation-Confirmation Model (ECM) and user comfort levels with different data-sharing methods. Structural equation modeling was used to evaluate relationships between habit formation, satisfaction, perceived enjoyment, and perceived usefulness with continuous use. Wilcoxon signed-rank tests were used to analyze user comfort in sharing data, comparing noninternet- versus internet-based sharing methods and fully versus partially anonymized data. Results: A total of 273 responses were analyzed, with participants aged 18‐65 (mean 35.6, SD 11.7) years. The results indicate that continuous use of smartwatches is explained by habit (β=.35; P<.001) and satisfaction (β=.38; P<.001), which is in turn explained by perceived usefulness (β=.38; P<.001), perceived enjoyment (β=.32; P<.001), confirmation (β=.24; P<.001), and perceived usability (β=.10; P=.03). Smartwatch users preferred noninternet-based sharing options (z=−5.793; P<.001) when sharing data with their physician. Similarly, users were more comfortable sharing fully anonymized data with public health authorities than partially anonymized data (z=−3.592; P<.001). Conclusions: Habit formation and satisfaction emerged as pivotal drivers of continuous intention to use smartwatches, emphasizing the need for features that foster integration into daily routine and a rewarding user experience. Preferences for noninternet-based data sharing with physicians highlight privacy concerns that must be addressed to build users’ trust. By aligning device features and data-sharing protocols with user preferences, manufacturers, health care providers, and policy makers can enhance user engagement and maximize the potential of smartwatches to support individual health management and public health initiatives.


  • Open Access

    Determinants of Continuous Smartwatch Use and Data-Sharing Preferences with Physicians, Public Health Authorities, and Private Companies: A Survey of Smartwatch Users (Preprint)

    by Anthony James Goodings, Kayode Philip Fadahunsi, Derjung Tarn, Jennifer Lutomski, Frances Shiely, Patrick Henn, John O'Donoghue

    BACKGROUND Smartwatches are widely adopted globally for tracking health metrics, offering potential for enhancing individual healthcare and public health efforts. Continuous use of the devices and users’ willingness to share the data collected are critical to realizing their full benefits. This survey examines the key factors influencing continuous use of smartwatches and users’ comfort levels in sharing health data with healthcare providers, public health authorities, and private companies. OBJECTIVE To identify key factors that determine continuous smartwatch use and users’ comfort levels in sharing health data with healthcare providers and public health authorities. METHODS A cross-sectional online survey of current and past smartwatch users (age >18) was conducted to assess determinants of continuous use based on the Expectation-Confirmation Model (ECM) and user comfort levels with different data-sharing methods. Structural Equation Modeling (SEM) evaluated relationships between habit formation, satisfaction, perceived enjoyment, and perceived usefulness with continuous use. Wilcoxon Signed-Rank tests were used to analyse user comfort in sharing data, comparing non-internet versus internet-based sharing methods and fully versus partially anonymized data. RESULTS 273 responses were analyzed, with participants aged 18-65 years (mean = 35.6, SD = 11.7). Habit formation was the most significant factor influencing continuous smartwatch use, showing strong association with continuance intention (HAB1: 0.655, p < 0.001). Satisfaction (SAT1: 0.618, p < 0.001) and perceived enjoyment (e.g., ENJ3: 0.466, p < 0.001) also emerged as strong drivers. Smartwatch users preferred non-internet-based sharing options (Z = -5.793, p < 0.001) when sharing data with their physician. Similarly, users were more comfortable sharing fully anonymized data with public health authorities than partially anonymized data (Z = -3.592, p < 0.001). CONCLUSIONS Habit formation, satisfaction, and enjoyment emerged as pivotal drivers of continuous intention to use smartwatches, emphasizing the need for features that foster integration into daily routine and a rewarding user experience. When sharing with public health authorities, users expressed a preference for sharing fully anonymized data over partially anonymized data. Preferences for non-internet based data sharing with physicians highlights privacy concerns which must be addressed to build user trust. User trust is evidently lacking in private industry, which indicates that companies must take steps to build policy that promotes transparency in order to benefit from these data in the long term. By aligning device features and data-sharing protocols with user preferences, manufacturers, healthcare providers, and policymakers can enhance user engagement and maximize the potential of smartwatches to support individual health management and public health initiatives. INTERNATIONAL REGISTERED REPORT RR2-doi: 10.1136/bmjopen-2023-081228

  • Open Access

    From opt-out to opt-in consent for secondary use of medical data and residual biomaterial: An evaluation using the RE-AIM framework

    by Jennifer E. Lutomski, Peggy Manders

    Background: Patient records, imaging, and residual biomaterial from clinical procedures are crucial resources for medical research. In the Netherlands, consent for secondary research has historically relied on opt-out consent. For ethical-legal experts who purport passive consent undermines patient autonomy, opt-in consent (wherein affirmative action is required) is seen as the preferred standard. To date, there is little empirical research exploring patient feasibility, organizational consequences, and the potential risks for research based on secondary data. Thus, we applied the RE-AIM framework to evaluate the impact of migrating from an opt-out to an opt-in consent process. Methods: This evaluation was carried out in Radboud University Medical Center, a large tertiary hospital located in the southeast of the Netherlands. All non-acute, mentally competent patients ≥16 years of age registered between January 13, 2020 and June 30, 2023 were targeted (N = 101,437). In line with the RE-AIM framework, individual and organizational consequences were evaluated across five domains: reach, efficacy, adoption, implementation, and maintenance. Results: 101,437 eligible patients were approached of whom 66,214 (65.3%) consented, 8,059 (7.9%) refused consent and 27,164 (26.8%) had no response. Of the 74,273 patients with a response, 89.1% consented to secondary use. The migration to an opt-in consent system was modestly successful; yet notably, differential response patterns by key sociodemographic characteristics were observed. Adaptions to the process flow improved its effectiveness and resulted in a reasonable response over time. Implementation was most affected by budgetary restraints, thus impeding the iterative approach which could have further improved domain outcomes. Conclusion: This evaluation provides an overview of logistical and pragmatic issues encountered when migrating from opt-out to opt-in consent. Response bias remains a major concern. Though not always directly transferable, these lessons can be broadly used to inform other health care organizations of the potential advantages and pitfalls of an opt-in consent system.


  • Open Access

    Multimorbidity patterns in older persons and their association with self-reported quality of life and limitations in activities of daily living

    by Jennifer E. Lutomski, Trynke Hoekstra, Marjan van Den Akker, Jeanet Blom, Amaia Calderón-Larrañaga, Alessandra Marengoni, Alexandra Prados-Torres, Marcel Olde-Rikkert, Rene Melis


  • Open Access

    Expanding the boundaries of previously obtained informed consent in research: Views from participants in the Personalised Risk‐based Mammascreening study

    by Jennifer E. Lutomski, Linda Rainey, Milou de Jong, Peggy Manders, Mireille J. M. Broeders

    Introduction: Understanding participants' concerns and information needs regarding broadened consent is crucial to ensure transparency and participant autonomy. Our study qualitatively examined these issues in women participating in the Personalized RISk‐based MAmmascreening study (PRISMA). The original PRISMA informed consent was project‐specific (i.e., breast cancer research), limiting the scope of secondary research. We explored participants' needs for broadened consent to preserve informed decision‐making while maximising the potential re‐use of data.Methods: Focus groups (FGs) were performed following a semistructured discussion guide. Two independent researchers analysed the data thematically using an inductive approach.Findings: Twenty‐three asymptomatic women and 13 women diagnosed with breast cancer were randomly divided into six FGs. Four superordinate themes were identified: (1) Normalization, (2) Attitude towards the pharmaceutical industry, (3) Privacy and (4) Knowledge. Our participants viewed data sharing as an important conduit for advancing medical science. Perceived integrity was more often attributed to noncommercial than commercial parties, with a marked mistrust towards the pharmaceutical industry. Most requested information needs related to data protection. Participants' ideal consent process would confer a range of options; for example, they would be able to choose with whom data can be shared, whether data will be de‐identified or anonymous, the expiration date of their consent and how, if requested, general and personal study results would be disclosed.Conclusion: Our participants expressed clear information needs and a strong desire to be actively engaged in future data sharing decisions. Given that many researchers collaborate with commercial parties, building public confidence in these institutions would be beneficial. Illustrative examples addressing privacy concerns and clarifying difficult terms would aid consent decision‐making. Although our participants displayed great altruism in sharing their data and accepted that broad consent would ultimately facilitate future research, broad consent did not reflect their ideal situation. Dynamic consent may be an option but warrants further feasibility research.Patient and Public Contribution: Women were recruited from the general breast cancer screening population. Their perceptions and information needs, as reported in this study, will not only inform broadened consent for PRISMA but ideally guide other consent templates and decisions regarding consent processes.


  • Open Access

    FAIR data sharing: An international perspective on why medical researchers are lagging behind

    by Linda Rainey, Jennifer E Lutomski, Mireille Jm Broeders

    FAIR data, that is, Findable, Accessible, Interoperable, and Reusable data, and Big Data intersect across issues related to data storage, access, and processing. The solution-oriented FAIR principles serve an integral role in improving Big Data; yet to date, the implementation of FAIR in multiple sectors has been fragmented. We conducted an exploratory analysis to identify incentives and barriers in creating FAIR data in the medical sector using digital concept mapping, a systematic mixed methods approach. Thirty-eight principal investigators (PIs) were recruited from North America, Europe, and Oceania. Our analysis revealed five clusters rated according to perceived relevance: ‘Efficiency and collaboration’ (rating 7.23), ‘Privacy and security’ (rating 7.18), ‘Data management standards’ (rating 7.16), ‘Organization of services’ (rating 6.98), and ‘Ownership’ (rating 6.28). All five clusters scored relatively high and within a narrow range (i.e., 6.28–7.69), implying that each cluster likely influences researchers’ decision-making processes. PIs harbor a positive view of FAIR data sharing, as exemplified by participants highly prioritizing ‘Efficiency and collaboration’. However, the other four clusters received only modestly lower ratings and largely contained barriers to FAIR data sharing. When viewed collectively, the benefits of efficiency and collaboration may not be sufficient in propelling FAIR data sharing. Arguably, until more of these reported barriers are addressed, widespread support of FAIR data will not translate into widespread practice. This research lays the preliminary foundation for conducting targeted large-scale research into FAIR data practices in the medical research community.


  • Open Access

    Risk of bias assessment of sequence generation: a study of 100 systematic reviews of trials

    by Francesca Wuytack, Maria Regan, Linda Biesty, Pauline Meskell, Jennifer E. Lutomski, Martin O’dOnnell, Shaun Treweek, Declan Devane

    Systematic reviews of randomised trials guide policy and healthcare decisions. Yet, we observed that some reviews judge randomised trials as high or unclear risk of bias (ROB) for sequence generation, potentially introducing bias. However, to date, the extent of this issue has not been well examined. We evaluated the consistency in the ROB assessment for sequence generation of randomised trials in Cochrane and non-Cochrane reviews, and explored the reviewers’ judgement of the quality of evidence for the related outcomes. Cochrane intervention reviews (01/01/2017–31/03/2017) were retrieved from the Cochrane Database of Systematic Reviews. We also searched for systematic reviews in ten general medical journals with highest impact factors (01/01/2016–31/03/2017). We examined the proportion of reviews that rated the sequence generation domain as high, low or unclear risk of selection bias. For reviews that had rated any randomised trials as high or unclear risk of bias, we examined the proportion that had assessed the quality of evidence. Overall, 100 systematic reviews were included in our analysis. We evaluated 64 Cochrane reviews which comprised of 984 randomised trials; 0.8% (n = 8) and 52.2% (n = 514) were rated as high and unclear ROB for sequence generation respectively. We further evaluated 36 non-Cochrane reviews which comprised of 1376 trials; 5.8% (n = 80) and 39.6% (n = 545) were rated as high and unclear ROB respectively. Ninety percent (n = 10) of non-Cochrane reviews which rated randomised trials as high ROB for sequence generation did not report an underlying reason. All Cochrane reviews assessed the quality of evidence (GRADE). For the non-Cochrane reviews, only just over half had assessed the quality of evidence. Systematic reviews of interventions frequently rate randomised trials as high or unclear ROB for sequence generation. In general, Cochrane reviews were more transparent than non-Cochrane reviews in ROB and quality of evidence assessment. The scientific community should more strongly promote consistent ROB assessment for sequence generation to minimise selection bias and support transparent quality of evidence assessment. Consistency ensures that appropriate conclusions are drawn from the data.


  • Open Access

    The frail older person does not exist: development of frailty profiles with latent class analysis

    by W. M. Looman, I. N. Fabbricotti, J. W. Blom, A. P. D. Jansen, J. E. Lutomski, S. F. Metzelthin, R. Huijsman

    A fundamental issue in elderly care is targeting those older people at risk and in need of care interventions. Frailty is widely used to capture variations in health risks but there is no general consensus on the conceptualization of frailty. Indeed, there is considerable heterogeneity in the group of older people characterized as frail. This research identifies frailty profiles based on the physical, psychological, social and cognitive domains of functioning and the severity of the problems within these domains. This research was a secondary data-analysis of older persons derived from The Older Person and Informal Caregiver Minimum Dataset. Selected respondents were 60 years and older (n = 43,704; 59.6% female). The following variables were included: self-reported health, cognitive functioning, social functioning, mental health, morbidity status, and functional limitations. Using latent class analysis, the population was divided in subpopulations that were subsequently discussed in a focus group with older people for further validation. We distinguished six frailty profiles: relatively healthy; mild physically frail; psychologically frail; severe physically frail; medically frail and multi-frail. The relatively healthy had limited problems across all domains. In three profiles older people mostly had singular problems in either the physical or psychological domain and the severity of the problems differed. Two remaining profiles were multidimensional with a combination of problems that extended to the social and cognitive domains. Our research provides an empirical base for meaningful frailty profiles. The profiles showed specific patterns underlying the problems in different domains of functioning. The heterogeneous population of frail older people has differing needs and faces different health issues that should be considered to tailor care interventions. Evaluation research of these interventions should acknowledge the heterogeneity of frailty by profiling.


  • Open Access

    The Radboud Biobank: A Central Facility for Disease-Based Biobanks to Optimise Use and Distribution of Biomaterial for Scientific Research in the Radboud University Medical Center, Nijmegen

    by Peggy Manders, Jennifer E. Lutomski, Cees Smit, Dorine W. Swinkels, Gerhard A. Zielhuis

    The Radboud Biobank offers disease-based biobanks a centralized facility to optimize the use and distribution of biomaterial for scientific research. Notably, two population biobanks are also included in this collection. All collections are professionally and sustainably maintained using high-quality and secure standardized protocols for ICT, legal-ethical aspects, sample collection, processing and storage, communication and distribution. The Radboud Biobank includes biomaterial (e.g. DNA, serum, plasma, tissue, urine and faeces – depending on the specific patient group), images, associated clinical data (patient, disease-specific and phenotypic data) and derived information (genotypic data, microarray gene expressions). Patient advocates and other relevant stakeholders are actively involved in the governance of the Radboud Biobank. Funding statement: The Radboud Biobank was implemented by the Radboudumc Executive Board as part of the university research infrastructure. It is a central facility for the Radboudumc, with guaranteed central support for at least 15 years. A governing strategic board, encompassing relevant stakeholder groups, oversees the operations of the Radboud Biobank. Two patient representatives are included in this strategic board, and one holds the position of chairperson.


  • Rasch analysis reveals comparative analyses of activities of daily living/instrumental activities of daily living summary scores from different residential settings is inappropriate

    by Jennifer E. Lutomski, Paul F.M. Krabbe, Wendy P.J. Den Elzen, Marcel G.M. Olde-Rikkert, Ewout W. Steyerberg, Maaike E. Muntinga, Nienke Bleijenberg, Gertrudis I.J.M. Kempen, René J.F. Melis